Publication | Closed Access

DHPAC, a novel synthetic microtubule destabilizing agent, possess high anti-tumor activity in vincristine-resistant oral epidermoid carcinoma in vitro and in vivo

Tumor BiologyMedicinePharmacologyTumor TargetingAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer ResearchNovel Synthetic Microtubule